Tianjin Medical University General Hospital is a general hospital in the central Heping District of the Chinese metropolis of Tianjin, associated with Tianjin Medical University.

During the past decade, The General Hospital of Tianjin Medical University conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 3 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The General Hospital of Tianjin Medical University" #1 sponsor was "Lifetech Scientific (Shenzhen) Co., Ltd." with 4 trials, followed by "Harbin Medical University" with 3 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored, "Peking Union Medical College Hospital" with 3 trials sponsored and "Chinese SLE Treatment And Research Group" with 3 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The General Hospital of Tianjin Medical University" #1 collaborator was "Peking Union Medical College Hospital" with 2 trials as a collaborator, "Abbott" with 1 trials as a collaborator, "Beijing Chao Yang Hospital" with 1 trials as a collaborator and "Beijing Novartis Pharma" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "The General Hospital of Tianjin Medical University" are "Stroke" (3 trials), "Acute Myocardial Infarction" (2 trials), "Alzheimer's Disease" (2 trials), "Heart Failure" (2 trials) and "Transient Ischemic Attack" (2 trials). Many other conditions were trialed in "The General Hospital of Tianjin Medical University" in a lesser frequency.

Most popular intervention types in "The General Hospital of Tianjin Medical University" are "Drug" (13 trials), "Device" (7 trials), "Combination Product" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "AZA" (1 trials), "Abdominal Aortic Aneurysm Stent Graft System" (1 trials), "Aegisy Vena Cava Filter" (1 trials) and "Amoxicillin-clavulantic acid" (1 trials). Other intervention names were less common.

The vast majority of trials in "The General Hospital of Tianjin Medical University" are 22 trials for "All" genders.

Currently, there are NaN active trials in "The General Hospital of Tianjin Medical University". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 10 completed trials in The General Hospital of Tianjin Medical University, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in The General Hospital of Tianjin Medical University, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 8 trials that are defined as “Not Applicable".